Mortality in Patients after a Recent Myocardial Infarction: A Randomized, Placebo-Controlled Trial of Azimilide Using Heart Rate Variability for Risk Stratification Academic Article uri icon

Overview

MeSH Major

  • Anti-Arrhythmia Agents
  • Heart Rate
  • Imidazoles
  • Imidazolidines
  • Myocardial Infarction
  • Piperazines
  • Potassium Channel Blockers

abstract

  • Azimilide did not improve or worsen the mortality of patients after MI. Low HRV independently identified a subpopulation at high risk of mortality.

publication date

  • March 2, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.CIR.0000117090.01718.2A

PubMed ID

  • 14967728

Additional Document Info

start page

  • 990

end page

  • 6

volume

  • 109

number

  • 8